Stefan Artlich serves as Director ‘Track & Trace’ at Bayer.
Being a mathematician and chemical engineer by profession Stefan is involved in pharmaceutical serialization since its early days in 2008 and renowned as one of the fathers of the European ‘Point-of-Dispense
Verification’ model that ensures patients’ access to safe medicines. Stefan played a key role in the design and development of the European Medicines Verification System and was responsible for the implementation of the EU Falsified Medicines Directive (FMD) at Bayer.
With the system in Europe being up and running and the implementation being complete, he now engages in identifying and exploiting the value of the newly introduced system in the digital transformation of the supply chain from the manufacturer down to the patient.
In 2016, Stefan was elected member of the GS1 Healthcare Leadership Team that he serves since then.